ROCKWOOL A/S
ROCKWOOL A/S – transactions in connection with share buy-back programme
ROCKWOOL A/S – transactions in connection with share buy-back programme
Company announcement
for ROCKWOOL A/S
Release no. 39 – 2025
to Nasdaq Copenhagen
18 June 2025
ROCKWOOL A/S – transactions in connection with share buy-back programme
As mentioned in announcement no. 07/2025, ROCKWOOL A/S has initiated a share buy-back programme which will run from 7 February 2025 until 5 February 2026. During this period, the Company will buy own shares for up to a maximum of 150 MEUR.
The programme is implemented in accordance with EU Commission Regulation No 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation.
The following transactions have been executed during the period 11 – 17 June 2025:
Date | Number of B shares | Average purchase price B shares (DKK) | Aggregate amount, B shares (DKK) |
[Accumulated, last announcement] | 1,241,500 | 354,647,646 | |
11 June 2025 | 10,000 | 311.49 | 3,114,900 |
12 June 2025 | 11,000 | 310.94 | 3,420,340 |
13 June 2025 | 15,000 | 297.57 | 4,463,550 |
16 June 2025 | 16,000 | 299.31 | 4,788,960 |
17 June 2025 | 17,000 | 296.80 | 5,045,600 |
Accumulated under the programme (B shares) | 1,310,500 | 375,480,996 |
With the transactions stated above, ROCKWOOL A/S owns 1,757,356 B shares corresponding to 0.83 percent of the Company’s total share capital.
An overview showing the transaction data for the period 11 – 17 June 2025 is enclosed.
Further information:
Kim Junge Andersen
Senior Vice President, CFO
ROCKWOOL A/S
+45 46 55 80 15
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Galapagos NV18.6.2025 22:01:00 CEST | Press release
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
1000 Miglia S.r.l.18.6.2025 18:34:51 CEST | Press release
1000 Miglia 2025: the arrival tonight in the capital
Siili Solutions Oyj18.6.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 18.6.2025
Zealand Pharma18.6.2025 17:29:44 CEST | Press release
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
Dassault Aviation18.6.2025 17:05:32 CEST | Press release
Dassault Aviation: Collaboration between AMIAD and Dassault Aviation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom